Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NRF
226
DELISTED
NorthStar Realty Finance Corp.
NRF
| $42M | 0.1% |
1,230,237
-378,831
| -24% | -$11.9M |
|
227
Deluxe
DLX
$1.09B
| $41.8M | 0.1% |
713,300
+22,600
| +3% | +$1.24M |
|
228
Jack Henry & Associates
JKHY
$10.9B
| $41.5M | 0.1% |
698,000
+12,000
| +2% | +$685K |
|
229
Coca-Cola Europacific Partners
CCEP
$47.1B
| $41.4M | 0.1% |
+865,800
| New | +$40M |
|
230
eBay
EBAY
$47.2B
| $41.2M | 0.1% |
1,955,305
-2,917,460
| -60% | -$63.6M |
|
|
OPLN
231
Openlane
OPLN
$4.48B
| $41.2M | 0.1% |
3,413,728
-577,621
| -14% | -$6.67M |
|
|
WDR
232
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $41M | 0.1% |
654,500
+459,518
| +236% | +$29.7M |
|
233
Credit Acceptance
CACC
$5.94B
| $40.8M | 0.1% |
331,600
+4,000
| +1% | +$528K |
|
234
Biogen
BIIB
$30.1B
| $40.8M | 0.1% |
+129,261
| New | +$38.9M |
|
|
BHI
235
DELISTED
Baker Hughes
BHI
| $40.7M | 0.09% |
546,940
+86,616
| +19% | +$6.03M |
|
236
Oil States International
OIS
$532M
| $40.5M | 0.09% |
632,000
+100,350
| +19% | +$5.9M |
|
|
SIAL
237
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $40.5M | 0.09% |
398,700
+85,400
| +27% | +$8.29M |
|
238
Quanta Services
PWR
$101B
| $40.2M | 0.09% |
1,161,399
+736,400
| +173% | +$25.5M |
|
239
Flowers Foods
FLO
$1.52B
| $39.9M | 0.09% |
1,891,082
-571,268
| -23% | -$11.8M |
|
240
Teleflex
TFX
$5.91B
| $39.6M | 0.09% |
375,400
+45,532
| +14% | +$4.78M |
|
|
MGAM
241
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
| $39.6M | 0.09% |
1,336,100
-144,700
| -10% | -$4.12M |
|
|
VRNT
242
DELISTED
Verint Systems
VRNT
| $39.3M | 0.09% |
1,571,912
+286,795
| +22% | +$6.75M |
|
243
ICU Medical
ICUI
$4.55B
| $39.3M | 0.09% |
645,500
-86,701
| -12% | -$5.12M |
|
|
PRXL
244
DELISTED
Parexel International Corp
PRXL
| $38.9M | 0.09% |
736,900
+91,600
| +14% | +$4.59M |
|
245
Gaming and Leisure Properties
GLPI
$12.4B
| $38.7M | 0.09% |
1,138,256
+896,155
| +370% | +$31.3M |
|
246
Boston Beer
SAM
$1.85B
| $38.6M | 0.09% |
172,900
+11,170
| +7% | +$2.55M |
|
247
Ashland
ASH
$3.42B
| $38.6M | 0.09% |
725,978
+416,976
| +135% | +$20.8M |
|
|
TWO
248
Two Harbors Investment
TWO
$1.26B
| $38.5M | 0.09% |
459,775
+248,544
| +118% | +$20.7M |
|
|
RAD
249
DELISTED
Rite Aid Corporation
RAD
| $38.5M | 0.09% |
268,244
+188,594
| +237% | +$27.8M |
|
|
ALXN
250
DELISTED
Alexion Pharmaceuticals
ALXN
| $38.4M | 0.09% |
+245,552
| New | +$38.8M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.